Wikisage, the free encyclopedia of the second generation, is digital heritage
Midazolam: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
(File:Mitte x-Midazolam.jpg) |
||
| (12 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
Midazolam is a benzodiazepine with the advantage of multiple routes of administration, due to its water solubility. At physiologic pH the ring structure of midazolam closes and it becomes highly lipophilic, crossing the blood-brain barrier rapidly. | Midazolam is a benzodiazepine with the advantage of multiple routes of administration, due to its water solubility. At physiologic pH the ring structure of midazolam closes and it becomes highly lipophilic, crossing the blood-brain barrier rapidly.<ref>Patsalos PN, Bell DM, Richards G, Sander JWAS, Oxley JR, Dhillion S, Cromarty J. Pharmacokinetic evaluation of intravenous and intramuscular midazolam in patients with epilepsy. Epilepsia. 1991;32(suppl. 1):29.</ref> | ||
==Weblinks== | |||
Status epilepticus | [[Status epilepticus]] | ||
== == | == == | ||
lorazepam>diazepam<ref>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641362/pdf/12883_2015_Article_486.pdf Making SENSE--Sustained Effort Network for treatment of Status Epilepticus as a multicenter prospective registry.</ref> | [[lorazepam]]>[[diazepam]]<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641362/pdf/12883_2015_Article_486.pdf Making SENSE--Sustained Effort Network for treatment of Status Epilepticus as a multicenter prospective registry.]</ref> | ||
<ref> | <ref> | ||
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/ Pharmacotherapy for Status Epilepticus</ref> | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/ Pharmacotherapy for Status Epilepticus]</ref> | ||
<ref>http://www.nice.org.uk/guidance/cg137/resources/epilepsies-diagnosis-and-management-35109515407813</ref> | <ref>[http://www.nice.org.uk/guidance/cg137/resources/epilepsies-diagnosis-and-management-35109515407813 ]</ref> | ||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3211107/pdf/nihms311183.pdf RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): A double-blind randomized clinical trial of the efficacy of IM midazolam versus IV lorazepam in the pre-hospital treatment of status epilepticus by paramedics]</ref> | |||
<gallery> | |||
File:Midazolam_ball-and-stick_model.png | |||
File:Mitte x-Midazolam.jpg | |||
</gallery> | |||
==ATC== | |||
psycholeptics | |||
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 | |||
|colspan=2| <center> | |||
: [[wikipedia:midazolam|midazolam]] | |||
<ref>http://www.whocc.no/atc_ddd_index/?code=N05CD08</ref></center> | |||
|} | |||
[[wikipedia:midazolam|midazolam]] | |||
<references/> | <references/> | ||
[[Category:GABAA receptor positive allosteric modulators]] | |||
Latest revision as of 19:31, 13 October 2017
Midazolam is a benzodiazepine with the advantage of multiple routes of administration, due to its water solubility. At physiologic pH the ring structure of midazolam closes and it becomes highly lipophilic, crossing the blood-brain barrier rapidly.[1]
Weblinks
lorazepam>diazepam[2] [3] [4] [5]
ATC
psycholeptics
- ↑ Patsalos PN, Bell DM, Richards G, Sander JWAS, Oxley JR, Dhillion S, Cromarty J. Pharmacokinetic evaluation of intravenous and intramuscular midazolam in patients with epilepsy. Epilepsia. 1991;32(suppl. 1):29.
- ↑ Making SENSE--Sustained Effort Network for treatment of Status Epilepticus as a multicenter prospective registry.
- ↑ Pharmacotherapy for Status Epilepticus
- ↑ [1]
- ↑ RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): A double-blind randomized clinical trial of the efficacy of IM midazolam versus IV lorazepam in the pre-hospital treatment of status epilepticus by paramedics
- ↑ http://www.whocc.no/atc_ddd_index/?code=N05CD08